Raymond James Financial Inc. Decreases Stake in iShares U.S. Pharmaceuticals ETF $IHE

Raymond James Financial Inc. trimmed its position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 9.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 61,609 shares of the company’s stock after selling 6,443 shares during the period. Raymond James Financial Inc.’s holdings in iShares U.S. Pharmaceuticals ETF were worth $4,347,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also modified their holdings of IHE. Two Sigma Investments LP purchased a new stake in shares of iShares U.S. Pharmaceuticals ETF during the 4th quarter worth approximately $4,430,000. LPL Financial LLC raised its stake in iShares U.S. Pharmaceuticals ETF by 47.6% during the first quarter. LPL Financial LLC now owns 119,866 shares of the company’s stock valued at $8,458,000 after purchasing an additional 38,678 shares in the last quarter. Citadel Advisors LLC raised its stake in iShares U.S. Pharmaceuticals ETF by 265.7% during the fourth quarter. Citadel Advisors LLC now owns 18,708 shares of the company’s stock valued at $1,229,000 after purchasing an additional 13,592 shares in the last quarter. Liberty Wealth Management LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF during the first quarter valued at $848,000. Finally, Stifel Financial Corp purchased a new stake in iShares U.S. Pharmaceuticals ETF during the fourth quarter valued at $628,000.

iShares U.S. Pharmaceuticals ETF Trading Up 0.1%

Shares of NYSEARCA IHE opened at $71.32 on Friday. The firm’s 50-day moving average price is $68.34 and its 200-day moving average price is $67.31. The stock has a market capitalization of $584.82 million, a price-to-earnings ratio of 17.75 and a beta of 0.70. iShares U.S. Pharmaceuticals ETF has a 12-month low of $58.97 and a 12-month high of $73.28.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.